HealthEquity CEO Scott Cutler said GLP1s account for 7% of total prescription costs, so the company is trying to address the affordability crisis and looking at the role that HSAs can play
Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor JR
Specific findings from FDA inspections include failure to monitor cleanroom environments where sterile drugs are prepared, inadequate sterilization of equipment used in drug production, release of a batch of vitamin B6 despite microbial contamination detected in the production room, incomplete cleaning validation for equipment used in compounding implantable pellets, and repeat violations that were identified in previous inspections but not corrected
Fact: Benefits are most reliable in people with an actual deficiency
Enter John Eng, a physician-researcher working at the James J